RTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: Searching for effective cortical targets

Restorative Neurology and Neuroscience

Volumn 28, Issue 4, 2010, Pages 561-568

  Koch, Giacomo ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBELLUM; CLINICAL TRIAL; DRUG INDUCED DISEASE; DYSKINESIA; HUMAN; MOTOR NERVE CONDUCTION; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NERVE POTENTIAL; NEUROIMAGING; NEUROMUSCULAR FUNCTION; NEUROTRANSMISSION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION;

ANIMALS; ANTIPARKINSON AGENTS; CEREBELLUM; CEREBRAL CORTEX; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; PARKINSON DISEASE; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77956257529     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: 10.3233/RNN-2010-0556     Document Type: Review

References (56)

1. Aumann, T. D. (2002). Cerebello-thalamic synapses and motor adaptation. Cerebellum, 7(1), 69-77.
2. Ballanger, B., Baraduc, P., Broussolle, E., Le Bars, D., Desmurget, M., & Thobois, S. (2008). Motor urgency is mediated by the contralateral cerebellum in Parkinsons disease. J Neurol Neurosurg Psychiatry, 79(10), 1110-1116.
3. Baumer, T., Lange, R., Liepert, J., Weiller, C., Siebner, H. R., Rothwell, J. C., et al. (2003). Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans. Neuroimage, 20(1), 550-560.
4. Bezard, E., Brotchie, J. M., & Gross, C. E. (2001). Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci, 2(8), 577-588.
5. Brooks, D. J., Piccini, P., Turjanski, N., & Samuel, M. (2000). Neuroimaging of dyskinesia. Ann Neurol, 47(4 Suppl 1), S154- 158; discussion S158-159.
6. Brusa, L., Versace, V., Koch, G., Iani, C., Stanzione, P., Bernardi, G., et al. (2006). Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinsons disease. Clin Neurophysiol, 77 7(9), 1917-1921.
7. Buhmann, C., Gorsler, A., Baumer, T., Hidding, U., Demiralay, C., Hinkelmann, K., et al. (2004). Abnormal excitability of premotor-motor connections in de novo Parkinsons disease. Brain, 727(Pt 12), 2732-2746.
8. Calabresi, P., Di Filippo, M., Ghiglieri, V., & Picconi, B. (2008). Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord, 23(Suppl 3), S570-579.
9. Cenci, M. A. (2007). Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci, 30(5), 236243.
10. Centonze, D., Bernardi, G., & Koch, G. (2007). Mechanisms of disease: basic-research-driven investigations in humans-the case of hyperkinetic disorders. Nat Clin Pract Neurol, 3(10), 572-580.
11. Chen, R., Classen, J., Gerloff, C., Celnik, P., Wassermann, E. M., Hallett, M., et al. (1997). Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology, 48(5), 1398-1403.
12. Edwards, M. J., Talelli, P., & Rothwell, J. C. (2008). Clinical applications oftranscranial magnetic stimulation in patients with movement disorders. Lancet Neurol, 7(9), 827-840.
13. Fabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007). Levodopa-induced dyskinesias. Mov Disord, 22(10), 1379-1389; quiz 1523.
14. Fahn, S. (2000). The spectrum of levodopa-induced dyskinesias. AnnNeurol, 47(4 Suppl 1), S2-9; discussion S9-11.
15. Filion, M., Tremblay, L., & Bedard, P. J. (1991). Effects ofdopamine agonists on the spontaneous activity ofglobus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res, 547(1), 152-161.
16. Filipovic, S. R., Rothwell, J. C., van de Warrenburg, B. P., & Bhatia, K. (2009). Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinsons disease. Mov Disord, 24(2), 246-253.
17. Fisher, K.M., Lai, H.M., Baker, M.R., Baker, S.N. (2009) Corticospinal activation confounds cerebellar effects of posterior fossa stimuli. ClinNeurophysiol, 720(12), 2109-2113
18. Fukuda, M., Mentis, M. J., Ma, Y., Dhawan, V, Antonini, A., Lang, A. E., et al. (2001). Networks mediating the clinical effects of pallidal brain stimulation for Parkinsons disease: a PET study of resting-state glucose metabolism. Brain, 724(Pt 8), 1601-1609.
19. Guridi, J., Obeso, J. A., Rodriguez-Oroz, M. C., Lozano, A. A., & Manrique, M. (2008). L-dopa-induced dyskinesia and stereotactic surgery for Parkinsons disease. Neurosurgery, 62(2), 311-323; discussion 323-1315
20. Hariz, M. I., & Bergenheim, A. T. (2001). A 10-year follow-up review of patients who underwent Leksells posteroventral pallidotomy for Parkinson disease. JNeurosurg, 94(4), 552-558.
21. Hoshi, E., Tremblay, L., Feger, J., Carras, P. L., & Strick, P. L. (2005). The cerebellum communicates with the basal ganglia. NatNeurosci, 8(11), 1491-1493.
22. Huang, Y. Z., Edwards, M. J., Rounis, E., Bhatia, K. P., & Rothwell, J. C. (2005). Theta burst stimulation of the human motor cortex. Neuron, 45(2), 201-206.
23. Hurley, M. J., Mash, D. C., & Jenner, P. (2003). Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinsons disease examined by RT-PCR. Eur JNeurosci, 78(9), 2668-2672.
24. Ito, M. (2008). Control of mental activities by internal models in the cerebellum. Nat Rev Neurosci, 9(4), 304-313.
25. Khedr, E. M., Rothwell, J. C., Shawky, O. A., Ahmed, M. A., & Hamdy, A. (2006). Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinsons disease. Mov Disord, 27(12), 2201-2205.
26. Koch, G., Brusa, L., Caltagirone, C., Peppe, A., Oliveri, M., Stanzione, P., et al. (2005). rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology, 65(4), 623-625.
27. Koch, G., Brusa, L., Carrillo, F., Lo Gerfo, E., Torriero, S., Oliveri, M., et al. (2009). Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology, 73(2), 113-119.
28. Koch, G., Mori, F., Marconi, B., Codeca, C., Pecchioli, C., Salerno, S., et al. (2008). Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum. Clin Neurophysiol, 779(11), 2559-2569.
29. Lefaucheur, J. P., Drouot, X., Von Raison, F., Menard-Lefaucheur, I., Cesaro, P., & Nguyen, J. P. (2004). Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinsons disease. Clin Neurophysiol, 775(11), 2530-2541.
30. Lewis, M. M., Slagle, C. G., Smith, A. B., Truong, Y., Bai, P., McKeown, M. J., et al. (2007). Task specific influences of Parkinsons disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience, 747(1), 224235.
31. Lozano, A. M., Lang, A. E., Levy, R., Hutchison, W., & Dostrovsky, J. (2000). Neuronal recordings in Parkinsons disease patients with dyskinesias induced by apomorphine. Ann Neurol, 47(4 Suppl 1), S141-146.
32. Mally, J., & Stone, T. W. (1999). Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation. J Neurol Sci, 762(2), 179-184.
33. Marsden, C.D., Parkes, & J.D., Quinn, N. Fluctuations of disability in Parkinsons disease-clinical aspects. In: Marsden CD, Fahn S editors. Movement disorders III. Oxford: Butterworth-Heinemann; 1994. p. 180-199.
34. McDonnell, M.N., Orekhov, Y., & Ziemann, U. (2006). The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res, 773, 86-93.
35. Morgante, F., Espay, A. J., Gunraj, C., Lang, A. E., & Chen, R. (2006). Motor cortex plasticity in Parkinsons disease and levodopa-induced dyskinesias. Brain, 729(Pt4), 1059-1069.
36. Nimura, T., Ando, T., Yamaguchi, K., Nakajima, T., Shirane, R., Itoh, M., et al. (2004). The role of sigma-receptors in levodopa- induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. J Neurosurg, 700(4), 606-610.
37. Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., DeLong, M. R., & Olanow, C. W. (2000). Pathophysiology of levodopa- induced dyskinesias in Parkinsons disease: problems with the current model. Ann Neurol, 47(4 Suppl 1), S22-32; discussion S32-24.
38. Oliveri, M., Koch, G., Torriero, S., & Caltagirone, C. (2005). Increased facilitation of the primary motor cortex following 1 Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans. Neurosci Lett, 376(3), 188-193.
39. Pascual-Leone, A., Valls-Sole, J., Brasil-Neto, J. P., Cammarota, A., Grafman, J., & Hallett, M. (1994). Akinesia in Parkinsons disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology, 44(5), 892-898.
40. Piccini, P., Morrish, P. K., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., et al. (1997). Dopaminergic function in familial Parkinsons disease: a clinical and 18F-dopa positron emission tomography study. Ann Neurol, 47(2), 222-229.
41. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., et al. (2003). Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci, 6(5), 501-506.
42. Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000). A five-year study of the incidence of dyskinesia in patients with early Parkinsons disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med, 342(20), 1484-1491.
43. Rascol, O., Sabatini, U., Brefel, C., Fabre, N., Rai, S., Senard, J. M., et al. (1998). Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain, 727 (Pt 3), 527-533.
44. Rektorova, I., Sedlackova, S., Telecka, S., Hlubocky, A., & Rektor, I. (2008). Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinsons disease by repetitive transcranial magnetic stimulation. Int J Biomed Imaging, 2008, 372125.
45. Siebner, H. R., Mentschel, C., Auer, C., & Conrad, B. (1999). Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinsons disease. Neuroreport, 70(3), 589-594.
46. Siebner, H. R., Mentschel, C., Auer, C., Lehner, C., & Conrad, B. (2000). Repetitive transcranial magnetic stimulation causes a short-term increase in the duration ofthe cortical silent period in patients with Parkinsons disease. Neurosci Lett, 284(3), 147-150.
47. Siebner, H. R., Rossmeier, C., Mentschel, C., Peinemann, A., & Conrad, B. (2000). Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinsons disease. J Neurol Sci, 778(2), 91-94.
48. Starr, P. A., Vitek, J. L., & Bakay, R. A. (1998). Ablative surgery and deep brain stimulation for Parkinsons disease. Neurosurgery, 43(5), 989-1013; discussion 1013-1015.
49. Strafella, A., Ashby, P., Lozano, A., & Lang, A. E. (1997). Pallidotomy increases cortical inhibition in Parkinsons disease. Can JNeurol Sci, 24(2), 133-136.
50. Talelli, P., Greenwood, R. J., & Rothwell, J. C. (2007). Exploring Theta Burst Stimulation as an intervention to improve motor recovery in chronic stroke. Clin Neurophysiol, 778(2), 333342.
51. Tel, B. C., Zeng, B. Y., Cannizzaro, C., Pearce, R. K., Rose, S., & Jenner, P. (2002). Alterations in striatal neuropeptide mR-NA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience, 775(4), 1047-1058.
52. Ugawa, Y. (2009) Can we see the cerebellar activation effect by TMS over the back of the head? Clin Neurophysiol, 720(12), 2006-2007.
53. Wagle-Shukla, A., Angel, M. J., Zadikoff, C., Enjati, M., Gunraj, C., Lang, A. E., et al. (2007). Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology, 68(9), 704-705.
54. Young, M. S., Triggs, W. J., Bowers, D., Greer, M., & Friedman, W. A. (1997). Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinsons disease. Neurology, 49(5), 1278-1283.
55. Yu, H., Sternad, D., Corcos, D. M., & Vaillancourt, D. E. (2007). Role of hyperactive cerebellum and motor cortex in Parkinsons disease. Neuroimage, 35(1), 222-233.
56. Zeng, B. Y., Pearce, R. K., MacKenzie, G. M., & Jenner, P. (2000). Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated withL-DOPA. Eur J Neurosci, 72(3), 1096-1104.